Urol. praxi. 2019;20(2):54-57 | DOI: 10.36290/uro.2019.049

Treatment and prevention of recurrent urinary tract infections

MUDr. Miroslava Ryšánková
Urologická klinika, LF UK a FN v Hradci Králové

Recurrent urinary tract infections are frequent job description urology clinic. The most common are cystitis in women, prostatitis
in men. Other common recurrent diseases are pyelonephritis. Treatment of the infection itself is not difficult, but it is necessary to
treat it in a targeted manner. A further set of measures is more demanding to prevent recurrent attacks. Combination regimens,
natural preparations, immunoprophylaxis or chemoprophylaxis are combined.

Keywords: recurrent urinary tract infections, cystitis, prostatitis, pyelonefritis, prevention, immunoprophylaxis, chemoprophylaxis

Published: May 17, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšánková M. Treatment and prevention of recurrent urinary tract infections. Urol. praxi. 2019;20(2):54-57. doi: 10.36290/uro.2019.049.
Download citation

References

  1. Nicolle LE. Managing recurrent urinary tract infections in women. Womens health (Lond Engl) 2005; 1(1): 39-50. Go to original source... Go to PubMed...
  2. Stamm WE, Mc Kevitt M, Robersts PL, White NJ. Natural history of recurrent urinary tract infecions in women. Rev Infect Dis 1991; 13: 77-84. Go to original source... Go to PubMed...
  3. Foxman B, Somsel P, Tallman P. Urinary tract infection among women aged 40-65: behavioral and sexual risc factors. J Clin Epidemiol 2001; 54(7): 710-718. Go to original source... Go to PubMed...
  4. Lyerová L, Teplan T. Role imunoterapie v profylaxi recidivujících infekcí močových cest. Urolog. pro Praxi, 2010; 11(2): 64-68.
  5. De Muri PG, Wald ER. Imaging and antimicrobial prophylaxis following the diagnosis of urinary tract infection in children. Pediatr Infect Dis J. 2008; 27: 553-554. Go to original source... Go to PubMed...
  6. Kladenský J. Nekomplikované infekce dolních močových cest u žen - možnosti léčby a prevence. Urol. praxi, 2018; 19(1): 10-15. Go to original source...
  7. Bartoníčkova K. Uroinfekce, Praha: Galen 2000: 43-49.
  8. Howell AB, Vorsa N, Marderosian AD, Foo LY. Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proantokyanidin extracts from cranberries. N Engl J Med 1998; 339: 1085-1086. Go to original source... Go to PubMed...
  9. Micali S, Isgro G, Bianchi G, Miceli N, Calapai G, Navarra M. Cranberry and recurrent cystitis: More than marketing? Crit Rev Food Sci Nutr 2014; 54: 1063-1075. Go to original source... Go to PubMed...
  10. Miller JL, Krieger JN. Urinary tract infections cranberry juice, underwear, and probiotics in the 21st century. Urol Clin North Am 2002; 29(3): 695-699. Go to original source... Go to PubMed...
  11. Vidlař A, Burešova E, Študent V, Romžová M, Broďak M, Švihra J, Vostalova J, Šimanek V. Klikva velkoploda v profylaxi infekce močovych cest u pacientů s roztroušenou sklerozou a intermitentni katetrizaci. Pilotní placebem kontrolovana studie. Urol. praxi 2017; 18(2): 77-80. Go to original source...
  12. Kleinwachter M, Schung E, Selmer D. Glucosinolate-Myrosinase System in Nasturtium (Tropaeolum majus L.): Variability of Biochemical Parameters and Screening for Clones Feasible for Pharmaceutical Utilization. J Agric Food Chem 2008; 56(23): 11165-11170. Go to original source... Go to PubMed...
  13. Albrecht U, Goos KH, Schneider B. A randomised, double-blind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horse radish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections, Current Medical Research and Opinion 2007; 23(10): 2415-2422. Go to original source... Go to PubMed...
  14. Naber KG, Bergman B, Bishop MC, et al. Guidelines of Urinary and Male Genital Tract Infections. European Association of Urology, 2003.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.